Article date: December 2018
By: Chunliu Mi, Zhe Wang, Ming Yue Li, Zhi Hong Zhang, Juan Ma, Xuejun Jin in Volume 175, Issue 23, pages 4338-4352
Background and Purpose
IL‐1β is a cytokine of critical importance in inflammatory, infectious and autoimmune diseases. Zinc finger protein 91 (ZFP91) has been reported to be involved in multiple biological processes. Here, we identified a previously unknown role for ZFP91 in the production of biologically active IL‐1β and investigated the underlying mechanisms of its effects.
Experimental Approach
In vitro, the underlying mechanisms of ZFP91 at inhibiting the expression of IL‐1β were investigated by ELISA, RT‐PCR, Western blotting, immunoprecipitation and immunofluorescence assays. In vivo, colitis was induced by giving 4% dextran sulfate sodium (DSS) p.o. in drinking water for 5 days. Peritonitis was induced by injecting 700 μg alum i.p. for 12 h.
Key Results
ZFP91 activated the non‐canonical caspase‐8 inflammasome, which resulted in robust IL‐1β secretion. Using an immunoprecipitation assay and immunofluorescence assay, we found that ZFP91 promoted the assembly of the non‐canonical caspase‐8 inflammasome complex. Moreover, ZFP91 enhanced the activation of ERK, p38 MAPK and JNK in macrophages. In addition, our data demonstrate that the synthesis of pro‐IL‐1β is dependent on activation of these MAPK signalling pathways. In vivo experiments, the symptoms and colonic inflammation associated with DSS‐induced colitis were ameliorated in mice deficient in ZFP91. Furthermore, the inflammation in alum‐induced peritonitis was also attenuated in mice deficient in ZFP91.
Conclusions and Implications
Our research describes a mechanism by which ZFP91 promotes production of IL‐1β under physiological conditions and suggests that ZFP91 may be a promising therapeutic target for intervention in inflammatory, infectious and autoimmune‐related diseases.
DOI: 10.1111/bph.14493
View this article